Recombinant FVIIa in elective non‐orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review-Reference-Cited by-同舟云学术

Recombinant FVIIa in elective non‐orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review

Published:2021-03-10 Issue:3 Volume:27 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Dolan Gerard¹,Astermark Jan²³^ORCID,Hermans Cedric⁴^ORCID

Affiliation:

1. Guys’ and St Thomas’ NHS Trust London UK

2. Department of Translational Medicine Lund University Malmö Sweden

3. Department of Hematology, Oncology and Radiation Physics Skåne University Hospital Malmö Sweden

4. Haemostasis and Thrombosis Unit Division of Haematology Haemophilia Centre dCliniques universitaires Saint‐Luc Université catholique de Louvain Brussels Belgium

Funder

Novo Nordisk

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14291

Reference37 articles.

1. The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors;Castaman G;Blood Transfus,2017

2. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

3. Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors

4. WFH Guidelines for the Management of Hemophilia, 3rd edition

5. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders;Annals of Hematology;2023-06-30

2. Managing Relevant Clinical Conditions of Hemophilia A/B Patients;Hematology Reports;2023-06-07